2020-004863-14: A research study looking at how well a combination of the medicines semaglutide and NNC0480-0389 works in people with type 2 diabetes |
|
|
| Ongoing | 2 | 495 | Europe | NNC0480-0389 A 10 mg/mL, NNC0480-0389 A 30 mg/mL, Solution for injection, Solution for injection in pre-filled pen, Ozempic | Novo Nordisk A/S, Novo Nordisk A/S | Diabetes Mellitus, Type 2, Type 2 diabetes, Diseases [C] - Nutritional and Metabolic Diseases [C18] | | | | |
NCT05144984 / 2020-004863-14: A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes |
|
|
| Completed | 2 | 500 | Europe, Japan, US, RoW | NNC0480-0389, Semaglutide, Placebo (NNC080-0389), Placebo (semaglutide) | Novo Nordisk A/S, Novo Nordisk A/S | Diabetes Mellitus, Type 2 | 02/23 | 03/23 | | |
